HAPPINESS BIOTECH GROUP LTD (HAPP) Social Stream
HAPPINESS DEVELOPMENT GROUP LTD (HAPP) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering HAPP.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-08-04 | 1 | $3 | $3 | $3 | $4.5 | -33.33% |
Price Target Last Issued August 4, 2021
The Trend in the Analyst Price Target
HAPP's average price target has moved down $0 over the prior 16 days.
500 - Internal server error
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|
HAPP Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 1 | 0 | 0 | 0 | 0 | 1 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- HAPP has a greater number of analysts covering the stock than just about none of of all US stocks.
- In terms of how HAPPINESS DEVELOPMENT GROUP LTD fares relative to all US stocks, note that its variance in analysts' estimates is lower than almost 100% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, HAPPINESS DEVELOPMENT GROUP LTD's upside potential (average analyst target price relative to current price) is greater than 0.97% of them.
- HAPPINESS DEVELOPMENT GROUP LTD's average analyst price target is greater than 2.79% of Healthcare stocks.
In the Pharmaceutical Products industry, MDWD, NAII, and CYAN are the three stocks most similar to HAPPINESS DEVELOPMENT GROUP LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding HAPP using the data that counts. Try POWR Ratings for free.